IL6 and breast carcinoma: As presented in Figure 3A, CXCL8 (p = 0.12), IL6 (p = 0.022), and NFKB1 (p = 0.0097) mRNA levels were higher in breast cancer patients who did not respond to chemotherapy treatment.